IMM 1.61% 31.5¢ immutep limited

prof ian frazer close to skin cancer vaccine, page-16

  1. 23 Posts.
    Unable to find any info on Ian FRAZER re PRR, however found this on Neil FRAZER. Dr. Neil Frazer is Chief Medical Officer, Executive Director of Prima BioMed Limited. Dr Neil Frazer Dr Frazer was appointed the Company�s chief medical officer in November 2009. He is based in the United States, and plays a key role in overseeing Prima�s late-stage trials for its CVac� ovarian cancer treatment vaccine. Dr Frazer has more than 23 years experience in the pharmaceutical industry, including 10 years experience in oncology drug development, and has a depth of experience in managing the clinical development process of new drug applications. He has been involved in the applications for 10 new chemical entities in multiple therapeutic areas, plus more than 20 applications for line extensions of pharmaceutical drug applications. Dr Frazer has a Bachelor of Medicine and Bachelor of Surgery (MB ChB) from the University of Edinburgh Medical School, and has a Fellowship from the Royal College of Anaesthetists in London (FRCA) and a Fellowship in Pharmaceutical Medicine from the Royal College of Physicians.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.